# Non-invasive Imaging of Cetuximab-Zr. 89 Uptake Wit PET: a Phase I Trial in Stage IV Cancer Patients

> **NCT00691548** · PHASE1 · COMPLETED · sponsor: **Maastricht Radiation Oncology** · enrollment: 9 (actual)

## Conditions studied

- Stage IV Cancer

## Interventions

- **DRUG:** Cetuximab-Zr. 89

## Key facts

- **NCT ID:** NCT00691548
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2015-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00691548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00691548, "Non-invasive Imaging of Cetuximab-Zr. 89 Uptake Wit PET: a Phase I Trial in Stage IV Cancer Patients". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00691548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*